Treatment of Severe Breast Fungal Infection
For severe breast fungal infections caused by Candida species, treat with an echinocandin (caspofungin 70 mg loading dose then 50 mg daily, micafungin 100 mg daily, or anidulafungin 200 mg loading dose then 100 mg daily) for 2 weeks after clearance of infection or resolution of skin lesions. 1
Initial Assessment and Pathogen Identification
The management approach depends critically on whether this is a superficial breast/nipple candidiasis versus a deep tissue or implant-associated fungal infection:
For Deep Tissue or Implant-Associated Candida Infections
First-line therapy: Echinocandins are the preferred agents for severe Candida skin and soft tissue infections, particularly in critically ill patients 1
Alternative for Candida parapsilosis specifically: Lipid formulation amphotericin B (3-5 mg/kg daily) is preferred over echinocandins, as C. parapsilosis has reduced echinocandin susceptibility 1
Fluconazole as step-down therapy: After clinical stabilization and documented susceptibility, fluconazole 400 mg daily can be used to complete the treatment course 1
Duration of Treatment
- Continue therapy for 2 weeks after clearance of bloodstream infection or complete resolution of skin lesions 1
- Premature discontinuation can lead to relapse, particularly in disseminated infections 2
Critical Considerations for Drug-Resistant Candida
If multidrug-resistant Candida albicans is suspected or documented (resistant to amphotericin B, fluconazole, itraconazole, and voriconazole):
- Echinocandins remain effective and should be used as targeted therapy 3
- Obtain fungal cultures with antifungal susceptibility testing to guide therapy 3
- Caspofungin successfully treated a documented case of multidrug-resistant C. albicans breast implant infection 3
Special Situations
For Candida krusei infections:
- Use an echinocandin, lipid formulation amphotericin B, or voriconazole (C. krusei is intrinsically fluconazole-resistant) 2
For suspected invasive candidiasis in critically ill patients:
- Start empiric echinocandin therapy immediately if the patient shows signs of septic shock with risk factors for invasive candidiasis 2
- Do not delay treatment while awaiting culture results in hemodynamically unstable patients 2
Important Caveats
Avoid overdiagnosis in lactational breast pain: Recent evidence suggests that superficial nipple/breast pain in breastfeeding women is frequently overdiagnosed as candidiasis and overtreated with antifungals 4. However, this does NOT apply to severe, deep tissue fungal infections requiring systemic therapy.
Surgical management may be necessary: For implant-associated infections, capsulectomy and implant removal/replacement may be required in addition to antifungal therapy 3. For abscesses, radiological or surgical drainage is often needed alongside antimicrobial therapy 5.
Monitor for polymicrobial infection: Breast infections are frequently polymicrobial (57.5% mixed growth in one series), so consider adding antibacterial coverage if bacterial co-infection is suspected 5.